Current progress in CAR-T cell therapy for tumor treatment

Chimeric antigen receptor T (CAR-T) cells are a type of tumor immunotherapy that is a breakthrough technology in the clinical treatment of tumors. The basic principle of this method is to extract the patient's T cells and equip them with targeting recognition receptors of tumor cells and return...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Xie, Ting, Wei, Bing, Di, Da-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478623/
https://www.ncbi.nlm.nih.gov/pubmed/36168313
http://dx.doi.org/10.3892/ol.2022.13478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478623/
https://www.ncbi.nlm.nih.gov/pubmed/36168313
http://dx.doi.org/10.3892/ol.2022.13478

Ejemplares similares